Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
Hamilton, K., Chatterji, P., Andres, S., Lundsmith, E., Whelan, K., Mizuno, R., Giroux, V., Mah, A., Chua, L., Hicks, P., et al. (2016). O-010 Novel Regulation of Autophagy and Intestinal Homeostasis Via mRNA Binding Protein IMP1.Inflamm Bowel Dis22 Suppl 1, S4.
VanDussen, K., Miyoshi, H., Sonnek, N., Ciorba, M., and Stappenbeck, T. (2016). O-013 Defining the Basis of Epithelial Defects in Crohn's Using Intestinal Spheroid Culture.Inflamm Bowel Dis22 Suppl 1, S1-S80.
Ribas, A. (2015). O8.2Putting adoptive T cell therapy on the path to regulatory approval.Ann Oncol26, ii12.
Benites, B.Deltreggia, Gilli, S.Cristina O., and Saad, S.Teresinha (2014). Obesity and inflammation and the effect on the hematopoietic system.Rev Bras Hematol Hemoter36, 147-151.
Venkatesan, V., Madhira, S.L., Malakapalli, V.M., Chalasani, M., Shaik, S.N., Seshadri, V., Kodavalla, V., Bhonde, R.R., and Nappanveettil, G. (2013). Obesity, Insulin Resistance, and Metabolic Syndrome: A Study in WNIN/Ob Rats from a Pancreatic Perspective.Biomed Res Int2013, 617569.
Tencerova, M., Frost, M., Figeac, F., Nielsen, T.Kamilla, Ali, D., Lauterlein, J.-J.Lindegaard, Andersen, T.Levin, Haakonsson, A.Kristian, Rauch, A., Madsen, J.Skov, et al. (2019). Obesity-Associated Hypermetabolism and Accelerated Senescence of Bone Marrow Stromal Stem Cells Suggest a Potential Mechanism for Bone Fragility.Cell Rep27, 2050-2062.e6.
Teslow, E.A., Mitrea, C., Bao, B., Mohammad, R.M., Polin, L.A., Dyson, G., Purrington, K.S., and Bollig-Fischer, A. (2019). Obesity-induced MBD2_v2 expression promotes tumor-initiating triple negative breast cancer stem cells.Mol Oncol.
Janesick, A.S., and Blumberg, B. (2016). Obesogens: an emerging threat to public health.Am J Obstet Gynecol.
Baragli, L., Grande, C., Gesmundo, I., Settanni, F., Taliano, M., Gallo, D., Gargantini, E., Ghigo, E., and Granata, R. (2013). Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways.Plos One8, e64374.
Kamao, H., Mandai, M., Wakamiya, S., Ishida, J., Goto, K., Ono, T., Suda, T., Takahashi, M., and Kiryu, J. (2014). Objective Evaluation of the Degree of Pigmentation in Human iPS Cell-derived RPE.Invest Ophthalmol Vis Sci.
Nichane, M., and Loh, K.M. (2018). Obliterating Obstacles to an Odyssey.Cell Stem Cell23, 313-315.
Aguilar, P.R., Michelson, A.P., and Isakow, W. (2015). Obliterative Bronchiolitis.Transplantation.
Han, S., Dong, K., Shen, M., Wang, X., Jiang, W., Zhao, W., and Xu, D. (2019). Observation and mechanism study of bladder wound healing after transurethral holmium laser resection of bladder tumor.Lasers Med Sci.
Houck, P.D. (2015). "Observational Medicine" should be replaced by "Real Science".Med Hypotheses.
Andrade, C., Garag, S., Mahadevan, J., and Gorthi, N.V.S.S. (2019). Obsessive-compulsive symptoms in schizophrenia.Asian J Psychiatr40, 23.
Sforza, E., Thomas, T., Barthélémy, J.-C., Collet, P., and Roche, F. (2013). Obstructive Sleep Apnea is Associated with Preserved Bone Mineral Density in Healthy Elderly Subjects.Sleep36, 1509-1515.
Hubmann, M., Fritsch, S., Zoellner, A.-K., Prevalsek, D., Engel, N., Bücklein, V., Mumm, F., Schulz, C., Stemmler, H.Joachim, Jäger, G., et al. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.J Clin Virol82, 33-40.
Tantin, D. (2013). Oct transcription factors in development and stem cells: insights and mechanisms.Development140, 2857-2866.
Vázquez-Arreguín, K., Bensard, C., Schell, J.C., Swanson, E., Chen, X., Rutter, J., and Tantin, D. (2019). Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy.Plos Genet15, e1007687.
Wang, X., and Jauch, R. (2014). OCT4: A penetrant pluripotency inducer.Cell Regen (Lond)3, 6.
Monroy, E.Alonso Cru, Santos, P.Paulo de A., Lopes, M.Luiza Dini, Mosqueda-Taylor, A., Pinto, L.Pereira, and de Souza, L.Batista (2018). Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions.Histochem Cell Biol.
Ng, W.L., Chen, G., Wang, M., Wang, H., Story, M., Shay, J.W., Zhang, X., Wang, J., Amin, A.R.M.R., Hu, B., et al. (2014). OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.Cell Death Dis5, e1024.
Wu, G., Wilson, G., Zhou, G., Hebbard, L., George, J., and Qiao, L. (2015). Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma.Discov Med20, 219-229.
Deveale, B., Brokhman, I., Mohseni, P., Babak, T., Yoon, C., Lin, A., Onishi, K., Tomilin, A., Pevny, L., Zandstra, P.W., et al. (2013). Oct4 is required ∼e7.5 for proliferation in the primitive streak.Plos Genet9, e1003957.
Tsai, L.-L., Hu, F.-W., Lee, S.-S., Yu, C.-H., Yu, C.-C., and Chang, Y.-C. (2014). Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition.Plos One9, e87207.